Publications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (2)

2025

  1. Does pregabalin offer potential as a first-line therapy for generalized anxiety disorder? A meta-analysis of efficacy, safety, and cost-effectiveness

    Frontiers in Pharmacology, Vol. 16

2022

  1. The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study

    European Neuropsychopharmacology, Vol. 57, pp. 105-117